# Health - General (GHG)

## Title 15. Assistance Programs

### Subtitle 6. Prescription Drug Repository Program

#### Section 15-601

(a) In this subtitle the following words have the meanings indicated.

(b) "Board" means the State Board of Pharmacy.

(c) "Dispense" means to provide:

  (1) A prescription drug or medical supply in accordance with a prescription; or

  (2) An over-the-counter drug or medical supply.

(d) "Drop-off site" means a pharmacy, other health care facility, or other entity participating in a drug donation or repository program and designated by the Board that:

  (1) Has voluntarily agreed to accept donated prescription drugs, over-the-counter drugs, or medical supplies;

  (2) Is located within the State or in another state; and

  (3) Does not have a final disciplinary order issued against it by a health occupations board.

(e) "Eligible patient" means an individual who, through self-attestation, is indigent, uninsured, underinsured, or enrolled in a public health benefits program.

(f) "Program" means the Prescription Drug Repository Program.

(g) "Repository" means a licensed pharmacy that:

  (1) If the licensed pharmacy is located in the State, does not have a final disciplinary order issued against it by the Board of Pharmacy;

  (2) Has voluntarily agreed to participate in the Program;

  (3) Is located in the State or in another state; and

  (4) Has been approved by the Board to:

    (i) Accept donated prescription drugs, over-the-counter drugs, or medical supplies from a designated drop-off site;

    (ii) Dispense the donated prescription drugs, over-the-counter drugs, or medical supplies to eligible patients; or

    (iii) Dispose of prescription drugs, over-the-counter drugs, or medical supplies not accepted for dispensing to eligible patients.

(h) "Tamper-evident packaging" means a packaging system that:

  (1) May involve an immediate-container and closure system, secondary-container or carton system, tertiary-container system, or other combination of systems intended to provide a visual indication of package integrity;

  (2) May contain unit-dose or multi-dose contents; and

  (3) Has one or more indicators or barriers to entry that:

    (i) If breached or missing, can reasonably be expected to provide visible evidence to consumers that tampering has occurred; and

    (ii) If handled in a reasonable manner during manufacture, distribution, or retail display, is designed to remain intact.

---

Md. Code Ann., Health-Gen. (as displayed at mgaleg.maryland.gov, October 16, 2026)